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During dehydration, protein kinase A phosphorylates
aquaporin 2 (AQP2) at serine 256 and this is essential for
apical membrane sorting of AQP2 in the collecting ducts.
A-kinase anchoring proteins (AKAPs) bind protein kinase A
and protein phosphatases conferring substrate specificity to
these enzymes and localize them to the appropriate
intracellular compartment. We found that AKAP220 bound to
AQP2 in a yeast two-hybrid screen. Further, it was highly
localized to the papilla compared to other regions of the
kidney. Using double immunofluorescence and
immunoelectron microscopy we found that AKAP220
co-localized with AQP2 in the cytosol of the inner
medullary collecting ducts. Forskolin-mediated phosphorylation
of AQP2, transiently expressed in COS cells, was increased
by AKAP220 co-expression. Our results suggest that
AKAP220 may be involved in the phosphorylation of AQP2
by recruiting protein kinase A.
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Aquaporin 2 (AQP2) is a water channel in the collecting ducts
of the kidney, and it is important in urine concentration. In
dehydrated animals, arginine vasopressin is released from the
pituitary gland and binds to the vasopressin type 2 receptor
on the basolateral plasma membrane of the collecting ducts,1
stimulates adenylate cyclase, and increases the cyclic AMP
concentration, thus activating cyclic AMP-dependent protein
kinase A (PKA). AQP2 is then phosphorylated at serine 256
by PKA,2,3 and this phosphorylation is a switch that
translocates AQP2 from the cytosol to the apical membrane.
Once AQP2 is inserted in the apical membrane, water
permeability of the collecting ducts increases, thus enabling
water reabsorption.4–6 Although the overall scheme of the
urine concentration mechanism is identified as described
above, the detailed mechanisms of AQP2 trafficking by AQP2
phosphorylation remain largely unknown. To gain insight
into this mechanism, the identification of molecules
surrounding AQP2 is an important step. Previously, we
isolated several AQP2-binding proteins by coimmunopreci-
pitation with anti-AQP2 antibody and mass spectrometry.7
However, this method only allowed us to identify the proteins
tightly bound to AQP2 even in the presence of detergents.
Although the yeast two-hybrid assay is a powerful tool to
identify proteins showing subtle binding ability within cells,
this strategy in our hands has not successfully identified
proteins bound to AQP2. Accordingly, to identify novel
AQP2-binding proteins, we adopted a new yeast two-hybrid
assay that uses split-ubiquitin technology.8 In contrast to the
conventional yeast two-hybrid assay, we could use whole
AQP2 as bait. By using the new yeast two-hybrid assay, we
identified A-kinase anchoring protein 220 (AKAP220) as an
AQP2-binding protein.
RESULTS
Isolation of AKAP220 by the yeast two-hybrid system
After two-hybrid screening under a stringent condition, a
clone encoding part of AKAP220 (residues 958–1306) was
isolated. To confirm the result of library screening, we again
transformed yeast cells with whole AQP2 and the isolated
AKAP220 clone alone or in combination (Figure 1a). Only
the yeast clone transformed with both plasmids could grow
on the selection plate, confirming the binding of both
http://www.kidney-international.org o r i g i n a l a r t i c l e
& 2008 International Society of Nephrology
Received 29 November 2007; revised 12 May 2008; accepted 4 June
2008; published online 13 August 2008
Correspondence: Shinichi Uchida, Department of Nephrology, Graduate
School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima,
Bunkyo-ku, Tokyo 113-8519, Japan. E-mail: suchida.kid@tmd.ac.jp
Kidney International (2008) 74, 1429–1433 1429
proteins in yeast cells. To further confirm that the binding
was not an artifact and to narrow down the binding sites
within each protein, we prepared deletion mutants of each
clone. As shown in Figure 1b, the deletion of the C-terminal
portion of AQP2 abolished the binding, suggesting that the
interaction site within AQP2 was located in the cytosolic C
terminus. In AKAP220, residues 1098–1186 contained a
binding site to AQP2 (Figure 1c). We could not further
narrow down the binding sites, as some yeast cells
transformed with other mutants did not grow well even on
the full medium for an unknown reason.
Immunolocalization of AKAP220 in the inner medullary
collecting ducts of rat kidney
To investigate whether AKAP220 could interact with AQP2 in
vivo, we performed immunoblot, immunofluorescence, and
immunoelectron microscopy of AKAP220 in rat kidney.
Immunoblot of the cortex, outer medulla, and papilla of rat
kidney clearly showed that AKAP220 was most abundant in
papilla (Figure 2a). Double immunofluorescence with AQP2
clearly showed that AKAP220 was mainly present in the inner
medullary collecting ducts, and under higher magnification
AKAP220 was colocalized with AQP2 in the subapical
cytoplasmic region (Figure 2b). Whether AKAP220 is also
present in the cortical and outer medullary collecting ducts
remains to be determined because of the relatively low
sensitivity of the antibody in immunofluorescence. To
confirm the close localization of AQP2 and AKAP220 in
vivo, we performed double immunoelectron microscopy
(Figure 2c). Although we detected fewer signals for AKAP220
(20-nm gold particles) as compared to the AQP2 signals (10-
nm gold particles), probably due to the lower sensitivity of
the anti-AKAP220 antibody, almost all AKAP220 was
colocalized with AQP2, confirming the direct affinity of
AKAP220 to AQP2 in vivo.
AKAP220 increased phosphorylation of AQP2
To gain insight into the functional role of AKAP220 in AQP2
phosphorylation, we investigated the phosphorylation status
of AQP2 transiently expressed in COS cells with or without
AKAP220 coexpression. Before the AQP2 phosphorylation
experiments, we confirmed that AKAP220 formed a complex
with PKA. As shown in Figure 3a, the catalytic and regulatory
subunits of PKA coimmunoprecipitated with AKAP220 as
previously reported. Under this condition, AQP2 phosphor-
ylation induced by forskolin was much higher (Po0.01,
1.98±0.07-fold increase, mean±s.d., n¼ 4) than in the
condition without AKAP220 coexpression (Figure 3b). This
phosphorylation of AQP2 measured by autoradiography was
confirmed to reflect the phosphorylation of AQP2 at serine
256 (the third lane in the upper panel of Figure 3b). In
addition, AKAP220 lacking the binding domain to AQP2 did
not elicit the phosphorylation of AQP2 (the fourth lane),
confirming that the binding site determined by the yeast two-
hybrid assay is important in the AQP2-AKAP220 interaction
in mammalian cells.
DISCUSSION
Phosphorylation of AQP2 by PKA is necessary for its apical
translocation in the collecting ducts. As this process occurs
within a minute,9,10 molecular mechanisms supporting
efficient AQP2 phosphorylation are necessary. As PKA has
broad substrate specificity and is present in relatively high
concentrations within cells, it is crucial to localize its activity
to its substrate. One way to accomplish this localization is by
anchoring the regulatory subunit of PKA to AKAPs,11,12
which target PKA in close proximity to relevant substrates.
Although more than 50 AKAPs have been identified by their
ability to bind to the regulatory subunits of the PKA
holoenzyme, there is no overall sequence similarity among
different AKAPs. Previously, several AKAPs were shown to be
present in AQP2-bearing vesicles by PKA overlay assays.13,14
Among them, AKAP18d was present on the same intracel-
lular vesicles as AQP2.15 Furthermore, AKAP18d was
translocated to the plasma membrane with AQP2 by
vasopressin stimulation, suggesting that AKAP18d was
involved in the AQP2 sorting machinery. However, neither
its direct binding ability to AQP2 nor its effect on AQP2
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Figure 1 | AKAP220 is an AQP2-binding protein. (a) Whole AQP2 (1-271) binds to a partial AKAP220 (958-1306). A yeast colony expressing
both AQP2 and AKAP220 could grow on the selection plate. (b) AQP2 without the C-terminal cytosolic region (1-224) could not bind
to AKAP220. (c) Residues from 1098 to 1186 in AKAP220 are involved in the binding to AQP2.
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phosphorylation was shown. In the present study, a new yeast
two-hybrid assay developed for membrane proteins identified
AKAP220 as a protein that binds to AQP2. This finding may
be physiologically relevant, as AKAP220 was colocalized with
AQP2 in rat kidney collecting ducts and AKAP220 enhanced
forskolin-induced AQP2 phosphorylation. Accordingly, at
least two AKAPs (AKAP18d and AKAP220) and possibly
several AKAPs may be involved in the regulated AQP2
trafficking by PKA stimulation.
A-kinase anchoring protein 220 was initially identified
as a protein binding to the regulatory subunit (RII) of
PKA.16–19 Its mRNA was detected in heart, brain, lung, testis,
and kidney by northern blot. However, the types of cells in
each organ that express AKAP220 have not been identified.
The present study clearly shows that AKAP220 is abundant in
the papilla in kidney, especially in the collecting ducts. As the
C-terminal sequence of AKAP220 (Cys-Arg-Leu) conforms
to a peroxisomal targeting signal motif,16 AKAP220 was
AKAP220
AKAP220
Actin
AQP2 Merge
10 µm
C OM P
Figure 2 | AKAP220 is present in the papillary collecting ducts
of the kidney. (a) Total lysates from rat cortex (C), outer medulla
(OM), and papilla (P) were separated by SDS–PAGE (27mg of
protein per lane) and immunoblotted with anti-AKAP220
antibody and anti-actin antibody. AKAP220 was detected only in
papilla. (b) Double immunofluorescence of AKAP220 and AQP2 in
the rat kidney. AKAP220 was mainly present in the collecting
ducts (upper panels) and colocalized with AQP2 in the subapical
cytoplasmic region of the collecting ducts (indicated by arrows).
(c) Double immunoelectron microscopy of AKAP220 and AQP2 in
the rat kidney. Almost all large (20-nm) gold particles (AKAP220)
were colocalized with small (10-nm) gold particles (AQP2;
indicated by arrows). Original magnification ( 20,000).
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Figure 3 | AKAP220 regulates the phosphorylation of AQP2 in
COS cells. (a) Total cell lysates from COS cells transfected with
either an empty vector or an HA-AKAP220 expression vector were
immunoprecipitated with anti-HA antibody. The
immunoprecipitates and total lysates were separated by
SDS–PAGE and transferred to a nitrocellulose membrane that was
then probed with antibodies to the catalytic and regulatory
subunits of PKA. (b) Increased AQP2 phosphorylation by
AKAP220. Demonstrable autoradiogram of phosphorylated AQP2
in COS cells with or without AKAP220 coexpression (upper
panels). In the third lane from the left, AQP2 phosphorylation was
not observed when serine 256 was mutated to alanine, indicating
that Ser256 was the only phosphorylation site by PKA in this assay
system. Full-length AKAP220 significantly increased AQP2
phosphorylation (second lane), whereas the mutant AKAP220
lacking the binding site to AQP2 did not increase AQP2
phosphorylation (fourth lane). Signal intensities of AQP2
phosphorylation measured by Image Gauge software (Fuji Film,
Tokyo, Japan) were compared with the paired t-test (bar graph;
Po0.01, n¼ 4).
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speculated to be a peroxisome AKAP; but the intracellular
localization of AKAP220 has not been fully investigated.
We performed a double immunofluorescence assay and
found that AKAP220 colocalized with AQP2 in the cytosol
near the apical membranes, suggesting that AKAP220
may be an endosomal AKAP. Very recently, AKAP11
(¼AKAP220) was identified as the most abundantly
expressed AKAP in the inner medullary collecting ducts
among various AKAPs;20 these results further support the
concept that AKAP220 is important for PKA signaling in the
collecting ducts.
The previously identified binding partner of AKAP220 is
glycogen synthase kinase-3b.21 PKA, type 1 protein phos-
phatase 1, glycogen synthase kinase-3b, and AKAP220 form a
quaternary complex. PKA and protein phosphatase
1 regulation of glycogen synthase kinase-3b activity was
more efficient when glycogen synthase kinase-3b was bound
to AKAP220. AKAP220 also coordinated the location of the
PKA RII and the type 1 protein phosphatase catalytic
subunit, which is important for regulating protein phospha-
tase catalytic activity.16,22
The binding sites on both proteins were investigated by
using deletion mutants of AKAP220 and AQP2 in the yeast
two-hybrid assay. We confirmed that the carboxy cytoplasmic
region of AQP2 and the middle portion of AKAP220
(residues 1085–1174) near the binding site to PP1 were
involved in their interaction. Thus, the binding of AQP2 and
AKAP220 was clearly demonstrated in yeast. However,
we could not successfully demonstrate their binding by
immunoprecipitation in COS cells and in rat kidney. The
failure of coimmunoprecipitation in rat kidney tissues may
be due to the lack of suitable AKAP220 antibodies for
immunoprecipitation. In COS cells, however, AKAP220 and
AQP2 were overexpressed, and immunoprecipitation was
performed with high-affinity antibodies to the tag (HA and
3 FLAG). Accordingly, we speculate that the interaction of
AQP2 and AKAP220 can be easily disrupted by detergents. In
the case of AKAP18d, its direct binding to AQP2 was not
demonstrated, although the proteins appeared to be
colocalized.14,15 As mentioned by Henn et al., AQP2 was
not included in protein complexes isolated by cyclic AMP-
agarose gel. This finding suggests that the interaction of the
PKA signaling complex and AQP2 may be weak, consistent
with the results of the present study. Although the binding
may be weak, the effect of AKAP220 on AQP2 phosphoryla-
tion was clearly demonstrated in Figure 3. As previously
shown, AKAP220 formed a complex with the regulatory and
catalytic subunits of PKA (as shown in Figure 3a). Under this
condition, AQP2 phosphorylation by forskolin with
AKAP220 was stronger than in the condition without
AKAP220 or with AKAP220 lacking the binding domain to
AQP2. This result also supports the notion that AKAP220 has
a binding affinity to AQP2 and recruits AQP2 in close
vicinity to PKA.
In summary, AKAP220 binds to AQP2 and may regulate
the phosphorylation of AQP2 in vivo.
MATERIALS AND METHODS
Yeast two-hybrid system that uses split ubiquitin
We performed the screening procedures according to the manu-
facturer’s (Dualsystems Biotech AG, Switzerland) recommendations.
Briefly, whole human AQP2 cDNA amplified by PCR was cloned
into the bait vector, pCCW-STE, transformed into the NMY32 yeast
strain, and selected on SD/-Leu plates at 30 1C for 3–4 days. Several
colonies were tested for autonomous activation on the selection
plates, SD/-tryptophan, -leucine, and -histidine. To create a more
stringent screening condition, 10 mM 3-amino-1,2,4-triazol was
added to the selection plates. A human kidney cDNA library
prepared in pDL2N-STE vector (Dualsystems Biotech AG) was
transformed into the bait vector-transformed yeast cells, which were
then incubated on the selection plates for 3–4 days. The plasmids in
the selected colonies were recovered according to the manufacturer’s
protocol, electroporated into Escherichia coli (DH 10B), and
sequenced.
Immunoblot and immunofluorescence of AKAP220 in rat
kidney
We divided the rat kidneys into the cortex, outer medulla, and papilla
under a dissecting microscope. Each section of rat kidney was
homogenized in a solution, which consisted of 150 mM NaCl, 50 mM
Tris-HCl (pH 8.0), and Complete (Roche, Indianapolis, IN) on ice,
and then centrifuged at 600 g at 4 1C for 15 min. The supernatants
were recovered and NP40 was added at the final concentration of 0.5%
volume. The samples were mixed with 2 SDS sample buffer,
denatured, resolved on SDS–polyacrylamide gel electrophoresis, and
transferred to Hybond-ECL membranes (Amersham, Uppsala,
Sweden). Anti-mouse AKAP220 antibody (BD Biosciences, San Jose,
CA) at a 1:200 dilution and anti-rabbit actin antibody (Cytoskeleton,
Denver, CO) at a 1:100 dilution were used.
For immunofluorescence, rat kidneys were obtained after perfusion
with 4% paraformaldehyde and 6 h of immersion in the same liquid at
4 1C Then, the tissues were immersed overnight in 20% sucrose/
phosphate-buffered saline at 4 1C and snap frozen in liquid nitrogen.
Cryostat sections of 10-mm thickness were prepared on slide glasses.
After blocking with 1% bovine serum albumin, the sections were
incubated overnight with anti-AKAP220 antibody and goat anti-AQP2
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 1C, washed
with phosphate-buffered saline several times, and then incubated with
Alexa Fluor 488-conjugated goat anti-mouse immunoglobulin G and
Alexa Fluor 546-conjugated donkey anti-goat immunoglobulin G
(diluted 1:200) at 37 1C for 30 min. Fluorescent images were obtained
by LSM510 Meta confocal microscopy.
Double immunoelectron microscopy was performed as described
previously.23 The secondary antibodies were rabbit anti-goat
immunoglobulin G(Hþ L), 10-nm gold (British Biocell Interna-
tional, London, UK) and rabbit anti-mouse immunoglobulin G, 20-
nm gold (EY Laboratories, San Mateo, CA).
Phosphorylation of AQP2
Full-length human AKAP220 cDNA with an N-terminal HA tag was
cloned into the pCGN vector.21 HA-tagged AKAP220 lacking amino
acids 1098–1186 was generated by PCR. Human AQP2 with N-
terminal 3 FLAG tag expression vector was prepared by PCR. An
S256A mutation was introduced by using a QuikChange kit
(Stratagene, La Jolla, CA). Both plasmids were cotransfected into
COS7 cells with Lipofectamine 2000. At 24 h after transfection, the
medium was replaced with phosphate-free Dulbecco’s modified
Eagle’s medium with 0.5% bovine serum albumin and 10 mM Hepes
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(pH 7.4) and incubated for 2 h, followed by further incubation for
2 h in the same medium containing 32[P]orthophosphate (1 mCi/
ml). These cells were then treated with 100 mM forskolin, 1 mM 3-
isobutyl-1-methyl-xanthine, and 200 mM 8-(4-chlorophenylthio)
adenosine 30,50-cyclic monophosphate for 30 min before harvest.
The cells were lysed for 1 h on ice in 150 mM NaCl, 15 mM Tris-HCl,
25 mM NaF, and 1 mM Na3VO4 (pH 8.0) and were immunopreci-
pitated with anti-FLAG M2 affinity gel. Immunoprecipitated AQP2
was resolved by SDS–polyacrylamide gel electrophoresis, and the
phosphorylation was visualized by autoradiography. Expression of
HA-AKAP220 and 3 FLAG AQP2 was confirmed by immunoblot
of the lysates with anti-HA and anti-FLAG antibodies, respectively.
Immunoprecipitation of HA-AKAP220 was performed by using
anti-HA affinity gel (Roche). Antibodies to catalytic and regulatory
subunits of PKA were purchased from BD Biosciences.
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